Doxycycline for community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.

Carter, Melinda K; Ebers, Vernessa A; Younes, Bachir K; Lacy, Melinda K

Carter, Melinda K; Ebers, Vernessa A; Younes, Bachir K; Lacy, Melinda K.

Ann Pharmacother ; 40(9): 1693-5, 2006 Sep.

Article in En | MEDLINE | ID: mdl-16896018

Subject(s)

Community-Acquired Infections/drug therapy; Doxycycline/therapeutic use; Methicillin Resistance; Staphylococcal Infections/drug therapy; Staphylococcus aureus; Adult; Aged; Community-Acquired Infections/epidemiology; Female; Humans; Male; Retrospective Studies; Skin Diseases, Infectious/drug therapy; Skin Diseases, Infectious/epidemiology; Soft Tissue Infections/drug therapy; Soft Tissue Infections/epidemiology; Staphylococcal Infections/epidemiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Infections / Staphylococcus aureus / Methicillin Resistance / Doxycycline / Community-Acquired Infections Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male Language: En Journal: Ann Pharmacother Year: 2006 Document type: Article

Search on Google

XML

PubMed Links